Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Cancer discovery
2018
HIF2α Antagonism Has Antitumor Activity in Advanced ccRCC.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
1 paper cites it
2018
this paper
cites it
HIF2α Antagonism Has Antitumor Activity in Advanced ccRCC. | OpenQuestion